ENTYVIO (VEDOLIZUMAB) APPROVED FOR TREATMENT OF IBD
We all know that finding a medication can be time consuming, a lot of trial and error, and sometimes when you find one that works it may work for you for awhile and then stop. Though biologics are very helpful for many patients, about 40% of patients do not have success with the current anti-TNF therapies available (remicade, humira, and cimzia). For these patients a medication with a different mechanism of action may be beneficial. Today the FDA approved Entyvio (vedolizumab) for treatment of adults with moderate to severe Crohn’s disease or ulcerative colitis.